Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal

Synapse

Volumn 60, Issue 7, 2006, Pages 553-556

  Olson, Valerie G ^a,b,c,d   Griner, Nicholas B ^a   Heusner, Carrie L ^a   Palmiter, Richard D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d GRECC   (United States)

Author keywords

Addiction; Conditioned place aversion; Dependence; Locus coeruleus; Morphine

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; CONTROLLED STUDY; GENE; GROOMING; JUMPING; MALE; MASTICATION; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; NPY GENE; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; TREMOR; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEAR; LIMBIC SYSTEM; MALE; MICE; MICE, KNOCKOUT; MORPHINE; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; NARCOTICS; NEURAL PATHWAYS; NEUROPEPTIDE Y; OPIOID-RELATED DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33749553043     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20328     Document Type: Article

References (25)

1. Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, Crow TJ, Tatemoto K, Polak JM. 1983. Neuropeptide Y distribution in human brain. Nature 306:584-586.
2. Aston-Jones G, Harris GC. 2004. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 (Suppl. 1):167-179.
3. Christie MJ, Williams JT, Osborne PB, Bellchambers CE. 1997. Where is the locus in opioid withdrawal? Trends Pharmacol Sci 18:134-140.
4. Clark JT, Kalra PS, Crowley WR, Kalra SP. 1984. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429.
5. Clausen TR, Moller M, Woldbye DP. 2001. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions. J Neurosci Res 64:410-417.
6. de Quidt ME, Emson PC. 1986. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 18:545-618.
7. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. 2000. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434.
8. Erickson JC, Clegg KE, Palmiter RD. 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y Nature 381:415-421.
9. Hawthorn J, Ang VT, Jenkins JS. 1984. Comparison of the distribution of oxytocin and vasopressin in the rat brain. Brain Res 307:289-294.
10. Heilig M. 2004. The NPY system in stress, anxiety and depression. Neuropeptides 38:213-224.
11. Holets VR, Hokfelt T, Rokaeus A, Terenius L, Goldstein M. 1988. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 24: 893-906.
12. Huffman RD, Simmons KE, Lum JT. 1985. An intraventricular infusion model for inducing morphine dependence in rats: Quantitative assessment of precipitated withdrawal. Behav Neurosci 99:861-880.
13. Koob GF. 2003. Alcoholism: Allostasis and beyond. Alcohol Clin Exp Res 27:232-243.
14. Maldonado R. 1997. Participation of noradrenergic pathways in the expression of opiate withdrawal: Biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104.
15. Olson VG, Heusner CL, Bland RJ, During MJ, Weinshenker D, Palmiter RD. 2006. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311:1017-1020.
16. Pages N, Orosco M, Fournier G, Rouch C, Hafi A, Gourch A, Comoy E, Bohuon C. 1991. The effects of chronic administration of morphine on the levels of brain and adrenal catecholamines and neuropeptide Y in rats. Gen Pharmacol 22:943-947.
17. Pages N, Orosco M, Rouch C, Fournier G, Comoy E, Bohuon C. 1992. Brain and adrenal monoamines and neuropeptide Y in codeine tolerant rats. Gen Pharmacol 23:159-163.
18. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ. 1990. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates. J Neurosci 10:2308-2317.
19. Thiele TE, Sparta DR, Hayes DM, Fee JR. 2004. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38:235-243.
20. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M. 2002. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 88:399-406.
21. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M. 2003. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology (Berl) 170:80-88.
22. Woldbye DP, Klemp K, Madsen TM. 1998. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. J Pharmacol Exp Ther 284:633-636.
23. You ZD, Li JH, Song CY, Wang CH, Lu CL. 2000. Chronic morphine treatment inhibits oxytocin synthesis in rats. Neuroreport 11:3113-3116.
24. Zachariou V, Thome J, Parikh K, Picciotto MR. 2000. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmacology 23:127-137.
25. Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR. 2003. The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci USA 100:9028-9033.